Article

Effectiveness of the Ad26.Cov2.S Vaccine in Health Care Workers in South Africa

2021-12-20

Abstract excerpt

Background: The Sisonke phase 3B open-label implementation study vaccinated health care workers (HCWs) with the single dose Ad26.COV2.S vaccine during two phases of the South African COVID-19 epidemic, dominated first by the Beta followed by the Delta variant of concern.<br><br>Methods: HCWs were vaccinated over 3 months (17 February -17 May 2021). Vaccine effectiveness (VE) against COVID-19 related hospitalisatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 023b95a2-61cf-51cf-b6c7-ded10a715ebc
DOI: 10.2139/ssrn.3979291

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of the Ad26.Cov2.S Vaccine in Health Care Workers in South AfricaDOI 10.2139/ssrn.3979291Read

Effectiveness of the Single-Dose Ad26.COV2.S COVID VaccineSemantic proximity Read

Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost after Prime with Ad26.COV2.S among Healthcare Workers in South Africa: the single-arm, open-label, Phase 3 SHERPA StudySemantic proximity Read

Primary Series COVID-19 Vaccine Effectiveness Among Health Care Workers in Albania, February–December 2021Semantic proximity Read

Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIVSemantic proximity Read

The Effectiveness of COVID-19 Vaccination in a Regional PopulationSemantic proximity Read

Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South AfricaSemantic proximity Read

Cost-effectiveness and cost-utility of COVID-19 vaccination in a South African privately insured population: a real-world claims-based analysisSemantic proximity Read

COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)Semantic proximity Read

The impact of COVID-19 on routine child immunisation in South AfricaSemantic proximity Read

Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19Semantic proximity Read

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 VariantSemantic proximity Read

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South AfricaSemantic proximity Read